CoChat

The interaction of streptococcal inhibitor of complement (SIC) and its proteolytic fragments with the human beta defensins

Fernie‐King, Barbara A., Seilly, David J., Lachmann, Peter J. · 2004 · Immunology
Cited by 78

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Summary: Streptococcal inhibitor of complement (SIC) is a 31 kDa extracellular protein produced by a few highly virulent strains of Streptococcus pyogenes (in particular the M1 strain). It has been shown additionally to inhibit four further components of the mucosal innate response—lysozyme, secretory leucocyte proteinase inhibitor, human α‐defensin 1 and the cathelicidin LL‐37 which are all bactericidal against Group A Streptococci (GAS). We now show that SIC also inhibits variably the antibacterial action of hBD‐1, ‐2 and ‐3. By enzyme‐linked immunosorbent assay (ELISA), SIC binds strongly to hBD‐2 and hBD‐3, but not at all to hBD‐1. Investigation of the antimicrobial action of β‐defensins hBD‐1, ‐2 and ‐3 against GAS in two different buffer systems shows that both the killing efficiencies of all three defensins, and the binding of SIC to them, occurs more efficiently in 10 m m Tris buffer than in 10 m m phosphate. The lower ionic strength of the Tris buffer may underlie this effect. hBD‐1 kills the M1 strain of GAS only in 10 m m Tris, but is able to kill an M6 (SIC negative) strain in 10 m m phosphate. The inhibition of hBD‐3 by SIC is clearly of physiological relevance, that of hBD‐2 is likely to be so, but the inhibition of hBD‐1 occurs only at lower ionic strength than is likely to be encountered in vivo. Elastase digestion of SIC yields three major fragments of MW 3·843 kDa comprising residues 1–33 (fragment A); 10·369 kDa comprising residues 34–126 (fragment B); and MW 16·487 kDa, comprising residues 127–273 (fragment C). By ELISA, only fragment B binds to hBD‐2 and hBD‐3 and this may indicate the inhibitory portion of the SIC molecule.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.0019-2805.2004.01837.x

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 78

Metadata

Authors
Fernie‐King, B. A., Seilly, D. J., & Lachmann, P. J.
Venue
Immunology
Publisher
Wiley
Published
2004-03-30
Volume
111
Issue
4
Pages
444-452
ISSN
  • 0019-2805 (ISSN-L)
  • 1365-2567
OpenAlex
W2086853751
Cited by
78
References
1
FWCI
5.02
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The interaction of streptococcal inhibitor of complement (SIC) and its proteolytic fragments with the human beta defensins. https://app.cochat.ai/papers/10.1111/j.0019-2805.2004.01837.x
The paper
Fernie‐King, B. A., Seilly, D. J., & Lachmann, P. J. (2004). The interaction of streptococcal inhibitor of complement (SIC) and its proteolytic fragments with the human beta defensins. Immunology. https://doi.org/10.1111/j.0019-2805.2004.01837.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.